The Shenzhen startup Lonvi Biosciences, which is engaged in longevity research, is developing a new drug that could potentially extend life to 120 years. This was reported by Kazinform, citing information from The New York Times.
According to the American publication, Lonvi Biosciences is focused on creating anti-aging pills using compounds extracted from grape seeds.
Company representatives claim that they have managed to isolate a unique molecule capable of destroying aging cells that can harm healthy tissues in the body.
The article emphasizes that grape seeds have long been considered a valuable resource in both Western medicine and traditional Chinese practices. According to the newspaper, Lonvi Biosciences has developed technology for creating capsules with a high content of active molecules.
The startup is confident that their pills, combined with a healthy lifestyle and quality medical care, can help people live to 120 years.
